S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

10x Genomics Stock Price, News & Analysis (NYSE:TXG)

$52.94
+0.44 (+0.84 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$52.15
Now: $52.94
$56.50
50-Day Range N/A
52-Week Range
$45.11
Now: $52.94
$63.38
Volume161,613 shs
Average Volume409,204 shs
Market Capitalization$4.97 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems. The company serves researchers in approximately 40 countries. Its customers include a range of academic, government, biopharmaceutical, biotechnology, and other institutions worldwide. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company was incorporated in 2012 and is based in Pleasanton, California.

Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone925-401-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees500
Market Cap$4.97 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive TXG News and Ratings via Email

Sign-up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.


10x Genomics (NYSE:TXG) Frequently Asked Questions

What is 10x Genomics' stock symbol?

10x Genomics trades on the New York Stock Exchange (NYSE) under the ticker symbol "TXG."

What price target have analysts set for TXG?

4 brokers have issued 1-year price objectives for 10x Genomics' shares. Their forecasts range from $55.00 to $70.00. On average, they expect 10x Genomics' stock price to reach $60.50 in the next twelve months. This suggests a possible upside of 14.3% from the stock's current price. View Analyst Price Targets for 10x Genomics.

What is the consensus analysts' recommendation for 10x Genomics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 10x Genomics in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for 10x Genomics.

Has 10x Genomics been receiving favorable news coverage?

Media stories about TXG stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. 10x Genomics earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for 10x Genomics.

Who are some of 10x Genomics' key competitors?

What other stocks do shareholders of 10x Genomics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 10x Genomics investors own include Home Depot (HD), Honeywell International (HON), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Amgen (AMGN), Cisco Systems (CSCO), Alibaba Group (BABA), CVS Health (CVS), Johnson & Johnson (JNJ) and Procter & Gamble (PG).

Who are 10x Genomics' key executives?

10x Genomics' management team includes the folowing people:
  • Dr. Serge Saxonov, Co-Founder, CEO & Director (Age 42)
  • Dr. Benjamin J. Hindson Ph.D., Co-Founder, Pres, Chief Scientific Officer & Director (Age 44)
  • Mr. Justin J. McAnear, Chief Financial Officer (Age 44)
  • Mr. Paul W. Wyatt, VP of Operations
  • Mr. Eric S. Whitaker, Gen. Counsel (Age 52)

When did 10x Genomics IPO?

(TXG) raised $297 million in an initial public offering (IPO) on Thursday, September 12th 2019. The company issued 9,000,000 shares at $31.00-$35.00 per share. J.P. Morgan, Goldman Sachs and BofA Merrill Lynch acted as the underwriters for the IPO and Cowen was co-manager.

When does the company's quiet period expire?

10x Genomics' quiet period expires on Tuesday, October 22nd. 10x Genomics had issued 10,000,000 shares in its public offering on September 12th. The total size of the offering was $390,000,000 based on an initial share price of $39.00. During the company's quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of 10x Genomics?

Shares of TXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is 10x Genomics' stock price today?

One share of TXG stock can currently be purchased for approximately $52.94.

How big of a company is 10x Genomics?

10x Genomics has a market capitalization of $4.97 billion. 10x Genomics employs 500 workers across the globe.View Additional Information About 10x Genomics.

What is 10x Genomics' official website?

The official website for 10x Genomics is http://www.10xgenomics.com/.

How can I contact 10x Genomics?

The company can be reached via phone at 925-401-7300.


MarketBeat Community Rating for 10x Genomics (NYSE TXG)

Community Ranking:  4.2 out of 5 (star star star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  1 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about 10x Genomics and other stocks. Vote "Outperform" if you believe TXG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TXG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel